The impact of enhanced recovery program compliance after elective liver surgery: Results from a multicenter prospective national registry
Raffaele Brustia(Assistance Publique – Hôpitaux de Paris), Jean-Romain Garric, M. Chalret du Rieu, Véronique Desfourneaux, K. Slim(Centre Hospitalier Universitaire de Clermont-Ferrand), Pascale Mariani(Université Paris Sciences et Lettres), Marie Queinnec, N. Sens, Adeline Germain, Aurélien Dupré(Centre Hospitalier Universitaire de Clermont-Ferrand), Ophélie Aumont, Alain Frisoni, Eddy Cotte(Hôpital Lyon Sud), Éric Levesque, N. Cheynel, Danièle Sommacale(Inserm), P. Goater(Institut Curie), Emmanuel Cuellar, Dimitri Tzanis(Université Paris Cité)
Cited by 21
Related Papers
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial
|The Lancet Oncology|2021|812
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial
|The Lancet. Gastroenterology & hepatology|2020|602
Predicting Survival After Hepatocellular Carcinoma Resection Using Deep Learning on Histological Slides
|Hepatology|2020|309
Is There a Possibility of a Cure in Patients With Colorectal Peritoneal Carcinomatosis Amenable to Complete Cytoreductive Surgery and Intraperitoneal Chemotherapy?
|Annals of Surgery|2013|270
2020 WSES guidelines for the detection and management of bile duct injury during cholecystectomy
|World Journal of Emergency Surgery|2021|254